Chinese General Practice ›› 2022, Vol. 25 ›› Issue (36): 4546-4553.DOI: 10.12114/j.issn.1007-9572.2022.0351
Special Issue: 精神卫生最新文章合集
• Article • Previous Articles Next Articles
Received:
2022-04-20
Revised:
2022-08-23
Published:
2022-12-20
Online:
2022-08-26
Contact:
WANG Yanfang
About author:
通讯作者:
王彦芳
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0351
组别 | 例数 | 性别〔n(%)〕 | 年龄〔M(P25,P75),岁〕 | 受教育年限〔M(P25,P75),年〕 | |
---|---|---|---|---|---|
男 | 女 | ||||
对照组 | 35 | 17(48.6) | 18(51.4) | 31(28,35) | 15(14,16) |
ASD+MD-组 | 78 | 23(29.5) | 55(70.5) | 34(27,40) | 14(9,15) |
ASD-MD+组 | 46 | 23(50.0) | 23(50.0) | 27(21,31)a | 15(11,15) |
ASD+MD+组 | 61 | 23(37.7) | 38(62.3) | 29(22,42) | 14(11,15) |
ASD-MD-组 | 24 | 4(16.7) | 20(83.3) | 25(21,35) | 14(13,15) |
H(χ2)值 | 11.517b | 17.003 | 10.394 | ||
P值 | 0.021 | 0.002 | 0.034 |
Table 1 Comparison of basic characteristics of major depressive disorder patients with different subtypes and healthy controls
组别 | 例数 | 性别〔n(%)〕 | 年龄〔M(P25,P75),岁〕 | 受教育年限〔M(P25,P75),年〕 | |
---|---|---|---|---|---|
男 | 女 | ||||
对照组 | 35 | 17(48.6) | 18(51.4) | 31(28,35) | 15(14,16) |
ASD+MD-组 | 78 | 23(29.5) | 55(70.5) | 34(27,40) | 14(9,15) |
ASD-MD+组 | 46 | 23(50.0) | 23(50.0) | 27(21,31)a | 15(11,15) |
ASD+MD+组 | 61 | 23(37.7) | 38(62.3) | 29(22,42) | 14(11,15) |
ASD-MD-组 | 24 | 4(16.7) | 20(83.3) | 25(21,35) | 14(13,15) |
H(χ2)值 | 11.517b | 17.003 | 10.394 | ||
P值 | 0.021 | 0.002 | 0.034 |
组别 | 例数 | HAMD-17总分 | 焦虑/躯体化 | 体质量 | 认知障碍 | 阻滞 | 睡眠障碍 |
---|---|---|---|---|---|---|---|
对照组 | 35 | 1(0,3) | 0(0,1) | 0(0,0) | 0(0,0) | 0(0,1) | 0(0,1) |
ASD+MD-组 | 78 | 21(19,24)ad | 7.5(7,8)acd | 0(0,1)a | 3(2,4)a | 6(5,7)a | 4(3,5)a |
ASD-MD+组 | 46 | 18(17,19)a | 5(5,6)a | 0(0,1) | 3(2,4)a | 6(5,7)a | 4(3,5)a |
ASD+MD+组 | 61 | 23(20,26)abc | 8(7,9)abc | 0(0,2)abc | 4(3,5)ab | 6(6,8)a | 4(3,5)a |
ASD-MD-组 | 24 | 17(17,23)a | 6(5,7)a | 0(0,0) | 4(3,4)a | 6(5,7)a | 4(2,5)a |
H值 | 128.060 | 179.152 | 30.505 | 96.164 | 96.285 | 63.782 | |
P值 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 |
Table 2 Comparison of the scores of HAMD-17 across major depressive disorder patients with different subtypes and healthy controls
组别 | 例数 | HAMD-17总分 | 焦虑/躯体化 | 体质量 | 认知障碍 | 阻滞 | 睡眠障碍 |
---|---|---|---|---|---|---|---|
对照组 | 35 | 1(0,3) | 0(0,1) | 0(0,0) | 0(0,0) | 0(0,1) | 0(0,1) |
ASD+MD-组 | 78 | 21(19,24)ad | 7.5(7,8)acd | 0(0,1)a | 3(2,4)a | 6(5,7)a | 4(3,5)a |
ASD-MD+组 | 46 | 18(17,19)a | 5(5,6)a | 0(0,1) | 3(2,4)a | 6(5,7)a | 4(3,5)a |
ASD+MD+组 | 61 | 23(20,26)abc | 8(7,9)abc | 0(0,2)abc | 4(3,5)ab | 6(6,8)a | 4(3,5)a |
ASD-MD-组 | 24 | 17(17,23)a | 6(5,7)a | 0(0,0) | 4(3,4)a | 6(5,7)a | 4(2,5)a |
H值 | 128.060 | 179.152 | 30.505 | 96.164 | 96.285 | 63.782 | |
P值 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 |
组别 | 例数 | 即刻记忆 | 视觉广度 | 言语功能 | 注意 | 延时记忆 | RBANS总分 |
---|---|---|---|---|---|---|---|
对照组 | 35 | 106(94,109) | 105(102,105) | 112(108,112) | 125(115,125) | 101(101,105) | 545(525,552) |
ASD+MD-组 | 78 | 83(73,87)a | 102(92,107)a | 96(87,101)a | 106(96,109)a | 85(81,99)a | 471(432,489)a |
ASD-MD+组 | 46 | 87(78,94)a | 102(90,109)a | 92(79,101)a | 106(102,112)a | 97(70,99)a | 481(446,493)a |
ASD+MD+组 | 61 | 81(69,83)ab | 100(100,109)a | 96(87,100)a | 112(100,112)a | 97(78,100)a | 493(419,495)a |
ASD-MD-组 | 24 | 76(76,90)a | 100(92,105)a | 92(74,100)a | 103(100,125)a | 91(83,97)a | 451(426,515)a |
H值 | 70.772 | 10.218 | 55.575 | 41.135 | 48.796 | 77.545 | |
P值 | 0.000 | 0.037 | 0.000 | 0.000 | 0.000 | 0.000 |
Table 3 Comparison of the scores of RBANS across major depressive disorder patients with different subtypes and healthy controls
组别 | 例数 | 即刻记忆 | 视觉广度 | 言语功能 | 注意 | 延时记忆 | RBANS总分 |
---|---|---|---|---|---|---|---|
对照组 | 35 | 106(94,109) | 105(102,105) | 112(108,112) | 125(115,125) | 101(101,105) | 545(525,552) |
ASD+MD-组 | 78 | 83(73,87)a | 102(92,107)a | 96(87,101)a | 106(96,109)a | 85(81,99)a | 471(432,489)a |
ASD-MD+组 | 46 | 87(78,94)a | 102(90,109)a | 92(79,101)a | 106(102,112)a | 97(70,99)a | 481(446,493)a |
ASD+MD+组 | 61 | 81(69,83)ab | 100(100,109)a | 96(87,100)a | 112(100,112)a | 97(78,100)a | 493(419,495)a |
ASD-MD-组 | 24 | 76(76,90)a | 100(92,105)a | 92(74,100)a | 103(100,125)a | 91(83,97)a | 451(426,515)a |
H值 | 70.772 | 10.218 | 55.575 | 41.135 | 48.796 | 77.545 | |
P值 | 0.000 | 0.037 | 0.000 | 0.000 | 0.000 | 0.000 |
组别 | 例数 | 潜伏期( | 波幅( | ||||
---|---|---|---|---|---|---|---|
Fz | Cz | Pz | Fz | Cz | Pz | ||
对照组 | 35 | 396.97±39.11 | 397.43±38.64 | 379.83±30.93 | 2.50±1.75 | 1.94±1.49 | 2.17±2.40 |
ASD+MD-组 | 78 | 392.87±38.10 | 394.04±37.42 | 392.86±33.78 | 2.75±2.09 | 2.24±1.44 | 2.33±2.60 |
ASD-MD+组 | 46 | 389.18±38.09 | 383.73±33.13 | 379.78±29.64 | 2.30±1.79 | 2.10±1.66 | 2.04±1.58 |
ASD+MD+组 | 61 | 393.15±35.25 | 394.21±36.81 | 387.72±32.89 | 2.10±1.57 | 1.96±1.52 | 2.27±1.79 |
ASD-MD-组 | 24 | 388.25±40.22 | 392.54±41.84 | 387.67±34.25 | 2.65±1.61 | 2.73±1.75 | 2.59±2.33 |
F值 | F组别=1.458,F电极点=2.369,F交互=0.552 | F组别=1.740,F电极点=1.094,F交互=0.361 | |||||
P值 | P组别=0.213,P电极点=0.094,P交互=0.817 | P组别=0.139,P电极点=0.335,P交互=0.941 |
Table 4 Comparison of amplitude and latency of N400 across major depressive disorder patients with different subtypes and healthy controls
组别 | 例数 | 潜伏期( | 波幅( | ||||
---|---|---|---|---|---|---|---|
Fz | Cz | Pz | Fz | Cz | Pz | ||
对照组 | 35 | 396.97±39.11 | 397.43±38.64 | 379.83±30.93 | 2.50±1.75 | 1.94±1.49 | 2.17±2.40 |
ASD+MD-组 | 78 | 392.87±38.10 | 394.04±37.42 | 392.86±33.78 | 2.75±2.09 | 2.24±1.44 | 2.33±2.60 |
ASD-MD+组 | 46 | 389.18±38.09 | 383.73±33.13 | 379.78±29.64 | 2.30±1.79 | 2.10±1.66 | 2.04±1.58 |
ASD+MD+组 | 61 | 393.15±35.25 | 394.21±36.81 | 387.72±32.89 | 2.10±1.57 | 1.96±1.52 | 2.27±1.79 |
ASD-MD-组 | 24 | 388.25±40.22 | 392.54±41.84 | 387.67±34.25 | 2.65±1.61 | 2.73±1.75 | 2.59±2.33 |
F值 | F组别=1.458,F电极点=2.369,F交互=0.552 | F组别=1.740,F电极点=1.094,F交互=0.361 | |||||
P值 | P组别=0.213,P电极点=0.094,P交互=0.817 | P组别=0.139,P电极点=0.335,P交互=0.941 |
变量 | HAMD-17总分 | 焦虑/躯体化 | 体质量 | 认知障碍 | 阻滞 | 睡眠障碍 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
r值 | P值 | r值 | P值 | r值 | P值 | r值 | P值 | r值 | P值 | r值 | P值 | |
Fz-L | 0.052 | 0.467 | 0.100 | 0.159 | 0.136 | 0.055 | -0.020 | 0.783 | 0.073 | 0.303 | -0.081 | 0.252 |
Fz-V | -0.074 | 0.299 | -0.090 | 0.202 | -0.021 | 0.765 | -0.170 | 0.016 | 0.111 | 0.118 | -0.015 | 0.830 |
Cz-L | 0.075 | 0.291 | 0.085 | 0.232 | 0.113 | 0.110 | 0.024 | 0.737 | 0.033 | 0.638 | -0.008 | 0.909 |
Cz-V | -0.033 | 0.642 | -0.119 | 0.092 | -0.090 | 0.204 | -0.098 | 0.168 | 0.151 | 0.033 | 0.041 | 0.560 |
Pz-L | 0.025 | 0.724 | 0.067 | 0.343 | 0.046 | 0.514 | -0.041 | 0.567 | 0.026 | 0.718 | -0.012 | 0.861 |
Pz-V | 0.122 | 0.085 | 0.065 | 0.362 | -0.035 | 0.626 | 0.062 | 0.383 | 0.174 | 0.014 | 0.040 | 0.573 |
Table 5 Correlation of N400 with the total score of HAMD-17 and its factor scores in major depressive disorder patients
变量 | HAMD-17总分 | 焦虑/躯体化 | 体质量 | 认知障碍 | 阻滞 | 睡眠障碍 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
r值 | P值 | r值 | P值 | r值 | P值 | r值 | P值 | r值 | P值 | r值 | P值 | |
Fz-L | 0.052 | 0.467 | 0.100 | 0.159 | 0.136 | 0.055 | -0.020 | 0.783 | 0.073 | 0.303 | -0.081 | 0.252 |
Fz-V | -0.074 | 0.299 | -0.090 | 0.202 | -0.021 | 0.765 | -0.170 | 0.016 | 0.111 | 0.118 | -0.015 | 0.830 |
Cz-L | 0.075 | 0.291 | 0.085 | 0.232 | 0.113 | 0.110 | 0.024 | 0.737 | 0.033 | 0.638 | -0.008 | 0.909 |
Cz-V | -0.033 | 0.642 | -0.119 | 0.092 | -0.090 | 0.204 | -0.098 | 0.168 | 0.151 | 0.033 | 0.041 | 0.560 |
Pz-L | 0.025 | 0.724 | 0.067 | 0.343 | 0.046 | 0.514 | -0.041 | 0.567 | 0.026 | 0.718 | -0.012 | 0.861 |
Pz-V | 0.122 | 0.085 | 0.065 | 0.362 | -0.035 | 0.626 | 0.062 | 0.383 | 0.174 | 0.014 | 0.040 | 0.573 |
变量 | 即刻记忆 | 视觉广度 | 言语功能 | 注意 | 延时记忆 | RBANS总分 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
r值 | P值 | r值 | P值 | r值 | P值 | r值 | P值 | r值 | P值 | r值 | P值 | |
Fz-L | 0.078 | 0.274 | -0.075 | 0.290 | -0.076 | 0.284 | 0.030 | 0.668 | -0.023 | 0.749 | 0.005 | 0.943 |
Fz-V | 0.138 | 0.050 | -0.057 | 0.425 | 0.052 | 0.462 | 0.050 | 0.483 | -0.036 | 0.612 | 0.054 | 0.449 |
Cz-L | -0.020 | 0.774 | -0.066 | 0.349 | -0.119 | 0.094 | -0.073 | 0.306 | -0.155 | 0.028 | -0.135 | 0.055 |
Cz-V | -0.057 | 0.425 | -0.075 | 0.288 | -0.052 | 0.467 | -0.094 | 0.186 | -0.113 | 0.112 | -0.097 | 0.173 |
Pz-L | -0.026 | 0.716 | -0.057 | 0.425 | 0.022 | 0.758 | -0.070 | 0.320 | -0.045 | 0.527 | -0.033 | 0.639 |
Pz-V | 0.018 | 0.799 | -0.050 | 0.484 | -0.015 | 0.833 | -0.053 | 0.454 | -0.033 | 0.644 | -0.039 | 0.581 |
Table 6 Correlation of N400 with the total score of RBANS and its factor scores in major depressive disorder patients
变量 | 即刻记忆 | 视觉广度 | 言语功能 | 注意 | 延时记忆 | RBANS总分 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
r值 | P值 | r值 | P值 | r值 | P值 | r值 | P值 | r值 | P值 | r值 | P值 | |
Fz-L | 0.078 | 0.274 | -0.075 | 0.290 | -0.076 | 0.284 | 0.030 | 0.668 | -0.023 | 0.749 | 0.005 | 0.943 |
Fz-V | 0.138 | 0.050 | -0.057 | 0.425 | 0.052 | 0.462 | 0.050 | 0.483 | -0.036 | 0.612 | 0.054 | 0.449 |
Cz-L | -0.020 | 0.774 | -0.066 | 0.349 | -0.119 | 0.094 | -0.073 | 0.306 | -0.155 | 0.028 | -0.135 | 0.055 |
Cz-V | -0.057 | 0.425 | -0.075 | 0.288 | -0.052 | 0.467 | -0.094 | 0.186 | -0.113 | 0.112 | -0.097 | 0.173 |
Pz-L | -0.026 | 0.716 | -0.057 | 0.425 | 0.022 | 0.758 | -0.070 | 0.320 | -0.045 | 0.527 | -0.033 | 0.639 |
Pz-V | 0.018 | 0.799 | -0.050 | 0.484 | -0.015 | 0.833 | -0.053 | 0.454 | -0.033 | 0.644 | -0.039 | 0.581 |
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
刘耀中,柳昀哲,林碗君,等. 抑郁障碍的核心脑机制——基于fMRI元分析的证据[J]. 中国科学:生命科学,2015,45(12):1214-1223. DOI:10.1360/N052015-00164.
|
[6] |
|
[7] |
王彦芳,杜巧荣,李素萍,等. 伴发睡眠障碍首发抑郁症认知功能损害及影响因素分析[J]. 中国神经精神疾病杂志,2015,41(2):71-75. DOI:10.3936/j.issn.1002-0152.2015.02.002.
|
[8] |
|
[9] |
张向红,马宁. 抑郁症严重程度与认知功能及事件相关电位的相关性分析[J]. 国际精神病学杂志,2021,48(6):997-1000. DOI:10.13479/j.cnki.jip.2021.06.011.
|
[10] |
|
[11] |
|
[12] |
|
[13] |
王玮,钱绍文,刘锴,等. 广泛性焦虑障碍发病机制的静息态功能磁共振成像[J]. 中国医学影像技术,2016,32(3):358-362.
|
[14] |
|
[15] | |
[16] |
|
[17] |
王勇,赵雅娟,赵国庆,等. 双相抑郁与首发抑郁症汉语成语N400的对照研究[J]. 精神医学杂志,2017,30(6):405-409. DOI:10.3877/cma.j.issn.1674-0785.2012.11.031.
|
[18] |
聂所成,王娟,刘畅. 老年抑郁症患者的认知功能与事件相关电位N400的表现[J]. 中国老年学杂志,2016,36(24):6209-6210. DOI:10.3969/j.issn.1005-9202.2016.24.078.
|
[19] |
|
[20] |
|
[21] |
|
[22] |
王勇,陈兴时,楼翡璎,等. 首发抑郁症患者新事件相关电位汉语成语N400的试验研究[J]. 中华临床医师杂志(电子版),2012,6(11):2966-2969. DOI:10.3877/cma.j.issn.1674-0785.2012.11.031.
|
[1] | DU Yeming, ZHANG Yunqiao, WANG Zongqi, MIN Xue, CUI Yalian, WANG Yanfang. Characteristics of Somatic Symptoms and Their Correlations with Brain-derived Neurotrophic Factor and Inflammatory Cytokinesin Patients with Major Depressive Disorder [J]. Chinese General Practice, 2023, 26(12): 1463-1471. |
[2] | Yu WU, Jue LIU, Min LIU, Wannian LIANG. Research of Epidemiologic Feature and Control of SARS-CoV-2 Omicron Subvariants BA.4 and BA.5 [J]. Chinese General Practice, 2022, 25(30): 3721-3725. |
[3] | Fangyi DENG, Rui TANG, Liqing ZHANG, Yixian CAI, Rong PAN, Jiyang PAN. Clinical Subtypes and Significanceof Adult Insomnia Disorders [J]. Chinese General Practice, 2022, 25(14): 1667-1673,1693. |
[4] | QIU Jian,CHENG Jinxiang1REN Jiafeng,SUN Shuyu,ZHAO Xianchao,JIANG Yingcong,SU Changjun. The Latent Class of Clinical Subtypes of Obstructive Sleep Apnea and the Analysis of Characteristics of Initial Exposure to CPAP Therapy [J]. Chinese General Practice, 2021, 24(14): 1745-1751. |
[5] | LOU Yue,QIAO Song,WANG Yanwen,CAI Miao,ZHUANG Liying,LIU Xiaoli. #br# Non-motor Symptoms in Early Parkinson's Disease with Three Different Motor Subtypes [J]. Chinese General Practice, 2021, 24(12): 1487-1493. |
[6] | YANG Chenghui,ZHOU Bo,ZHOU Fan,PAN Shuya,WANG Luyao,ZHONG Xuemei,HUANG Yulan,WANG Jinyu. Illness Perception in Patients with Somatic Symptom Disorder:Analysis of Current Status and Influential Factors [J]. Chinese General Practice, 2020, 23(32): 4039-4046. |
[7] | ZHANG Jinpeng,LI Xue,TAN Xi,DU Jian,ZHAO Mingyang,YOU Mingyan,ZHANG Yichunzi,KONG Junhui. Emotional Cognitive Impairment Regulated by Happy Emotional Induction in People with Subthreshold Depression:an Event-related Potential Study [J]. Chinese General Practice, 2019, 22(35): 4312-4317. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||